In-Vivo Epigenetic Reprogramming Reverses Cellular Aging Biomarkers in Longitudinal Mammalian Trials

Aging is increasingly recognized by biogerontologists not as an inevitable physical decay, but as a loss of epigenetic information. In groundbreaking longitudinal trials, scientists have successfully reversed biological age markers in cardiac and neural tissue using transient in-vivo expression of modified Yamanaka factors.

Restoring the Cellular Epigenetic Landscape

By pulsing the reprogramming factors for tightly controlled intervals, cells reset their DNA methylation patterns to a youthful state while preserving their differentiated cell identity, restoring youthful metabolic function and regenerative capacity.


Comments

Leave a Reply

Your email address will not be published. Required fields are marked *